Clinical Trial Update: Study of Immunogenicity & Safety of 2 Different Formulations of Human Rotavirus (HRV) Vaccine for the Prophylaxis of Rotavirus Gastroenteritis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two formulations of the Human Rotavirus Vaccine (HRV) for immunogenicity and safety in preventing rotavirus gastroenteritis. The study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Human Rotavirus Vaccine (HRV) (rotavirus vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Rotavirus | Phase 2 | Status: COMPLETED